Disopyramide

DICORYNAN 100 mg CAPSULAS DURAS

100 mg cápsula duraSpainMarketedAuthorised 31 Aug 1974

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Disopyramide

DICORYNAN 100 mg CAPSULAS DURAS

100 mg cápsula duraSpainMarketedAuthorised 31 Aug 1974

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Disopyramide PhosphateUnited States · 100MG BASE, 150MG BASE · capsule · Ivax Sub Teva Pharms

NorpaceUnited States · 100MG BASE, 150MG BASE · capsule · Pfizer

Norpace CRUnited States · 100MG BASE, 150MG BASE · capsule, extended release · Pfizer

Dicorantil FBrazil · Sanofi-Aventis Farmacêutica Ltda

Ritmodan RetardItaly · Compressa a rilascio prolungato · Cheplapharm Arzneimittel GMBH

Ritmoforine Retard 250 mg, tabletten met gereguleerde afgifteNetherlands · Tablet met gereguleerde afgifte · CHEPLAPHARM Arzneimittel GmbH

Norpace Ampoules 20MG/MLTaiwan · 注射劑 · 凱盛國際股份有限公司

Packs

Pack	Code	Status
DICORYNAN 100 mg CAPSULAS DURAS , 40 cápsulas	744359

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Disopyramide
Strength: 100 mg
Dosage form: cápsula dura
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 31 Aug 1974
Registration: 52549
Marketing authorisation holder: Cheplapharm Arzneimittel Gmbh
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración